Green Planet Bioengineering Co., Ltd. (GPLB) Fair Value 2026

GPLB · Shell Companies ·

By CirclFi Research Team · Data from SEC EDGAR, FRED & GDELT

Quality Score

3.4 /10

32 fundamental signals · 0 models active

Value Trap Risk

SAFE (0/100)

Quick Summary — As of 2026-08-27, Green Planet Bioengineering Co., Ltd. (GPLB) trades at $0.01. QOC: 3.4/10. Value Trap Risk: 0/100 (SAFE). 0/13 models active.

Key Facts

Ticker
GPLB
Price
$0.01
Quality Score
3.4/10
Value Trap Risk
0/100
Models Active
0/13
Last Updated
Strength: 0 independent models provide multi-angle coverage
Risk: Below-average Quality Score of 3.4/10 signals weak fundamentals

What Fair Value Does Each Model Give GPLB?

0 Intrinsic Value Models vs. Current Price ($0.01)

Core Models (Unlocked)
Model Fair Value Upside

All Models Active

All 0 models are displayed above.

What Is Green Planet Bioengineering Co., Ltd. (GPLB) Worth in 2026?

According to the CirclFi Deep Alpha Valuation Engine, Green Planet Bioengineering Co., Ltd. currently lacks sufficient data across our 13-model framework. As more financial data is processed from SEC filings, our models will generate intrinsic value estimates.

What Do the Models Say About GPLB?

0 of 13 models are currently active for GPLB. See which stocks rank higher →

How Does GPLB Rank in Shell Companies?

Among 36 Shell Companies stocks, GPLB ranks #28 by Quality of Company score. CirclFi's QOC score of 3.4/10 evaluates 32 fundamental signals. A score of 3.4 signals below-average fundamentals.

Green Planet Bioengineering Co., Ltd. operates in a competitive landscape where fundamental quality metrics are key differentiators for long-term value creation.

Is GPLB a Value Trap?

CirclFi's Value Trap algorithm assigns GPLB a score of 0/100 (SAFE). This indicates minimal risk. Fundamentals are healthy. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →

Multi-Model Methodology

0 of 13 models are active for Green Planet Bioengineering Co., Ltd.. Limited activation may indicate insufficient history. Each model applies a fundamentally different valuation philosophy. See the complete methodology →

According to the CirclFi 32-factor quality framework, Green Planet Bioengineering Co., Ltd.'s fundamental quality profile registers 3.4/10. This concerning score captures the company's profitability depth, growth consistency, balance sheet resilience, and shareholder return track record.

CirclFi runs 13 independent models for each stock. Browse all stocks with 13-model coverage →

Data Sources & Confidence

Every GPLB valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →

CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →

This analysis is produced by the CirclFi Valuation Engine using quantitative models applied to SEC EDGAR filings, public market feeds, and FRED macroeconomic indicators. It is not financial advice.

Read the full investment analysis: Should You Buy Green Planet Bioengineering Co., Ltd. Stock in 2026? →

Bull case, bear case, risk factors & peer comparison — updated daily

Which Similar Shell Companies Stocks Should You Also Analyze?

10 related Shell Companies stocks with 13-model coverage

AGLYAtlantis Glory Inc.QOC 3.6GLOHGlow Holdings, Inc.QOC 3.3ZLMEZhanling International LimitedQOC 3.6WNFTWorldwide NFT, Inc.QOC 3.2EEGIEline Entertainment Group, Inc.QOC 3.6FWFWFlywheel Advanced Technology, Inc.QOC 3.2WTGWintergreen Acquisition Corp.QOC 5.9BCARD. Boral ARC Acquisition I Corp.QOC 4.9CONCConectiSys CorporationQOC 4.1FVNFuture Vision II Acquisition Corp.QOC 5.8

Read investment analysis: AGLY · GLOH · ZLME · WNFT · EEGI · FWFW · WTG · BCAR · CONC · FVN

Which Other Stocks Have a Similar Quality Score to GPLB?

7 companies across all industries closest to GPLB’s Quality of Company score of 3.4/10.

CINGCingulate Inc.QOC 3.4HBNBHotel101 Global Holdings Corp.QOC 3.4FRMMForum Markets, IncorporatedQOC 3.4THHTryHard Holdings LimitedQOC 3.4SPMESound Point Meridian Capital, Inc.QOC 3.4ITGITG, Inc.QOC 3.3NVDANVIDIA CorporationQOC 10.0

Read investment analysis: CING · HBNB · FRMM · THH · SPME · ITG · NVDA

What Else Do Investors Ask About Green Planet Bioengineering Co., Ltd.’s Valuation?

What is Green Planet Bioengineering Co., Ltd.'s intrinsic value in 2026?

CirclFi does not yet have enough active models to publish a median fair value for Green Planet Bioengineering Co., Ltd. (GPLB). The Quality of Company score is 3.4/10 across 32 fundamental signals. All models use SEC EDGAR filings updated daily. See our methodology page for how each model works.

Is GPLB overvalued or undervalued right now?

At $0.01, 0 of 0 active models suggest GPLB may be undervalued, while 0 indicate potential overvaluation. The assessment depends on which methodology best fits Green Planet Bioengineering Co., Ltd.'s business model in Shell Companies.

What does a Quality of Company score of 3.4 mean for GPLB?

Green Planet Bioengineering Co., Ltd.'s QOC of 3.4/10 reflects 32 fundamental signals: profitability margins, revenue growth consistency, balance sheet leverage, free cash flow generation, and capital allocation efficiency. Scores below 5 flag potential fundamental weaknesses requiring careful analysis.

How many valuation models does CirclFi run on GPLB?

CirclFi analyzes GPLB with 13 institutional-grade models daily: Bayesian DCF (Monte Carlo + jump-diffusion), EPV (Greenwald zero-growth), EROIC Spread (McKinsey reinvestment), First Chicago (3-scenario), Markov DDM (regime-switching), ML-RIV (machine learning residual income), Dynamic NAV (asset-based), PWERM (option-theoretic), Regime Cross-Sectional (relative), Sentiment SOTP (hybrid), CUCE Ensemble (meta-model), FTNN Topology (neural network), and RCMH-DCF (conditional regime). Currently 0 of 13 are active for this stock. Read the full methodology →

Is GPLB a value trap in 2026?

Green Planet Bioengineering Co., Ltd.'s Value Trap score is 0/100 (SAFE). This low score indicates the current valuation is not artificially depressed by fundamental deterioration, suggesting genuine opportunity rather than a trap. Browse stocks by value-trap risk →

Cite this analysis — “CirclFi assigns Green Planet Bioengineering Co., Ltd. (GPLB) a Quality of Company score of 3.4/10 across 32 fundamental signals as of 2026-08-27.” Source: circlfi.com/stock/GPLB/ · Methodology
Primary sources for this GPLB valuation

Market data for GPLB as of ; valuations recomputed .